Old Web
English
Sign In
Acemap
>
authorDetail
>
Haifeng Zhang
Haifeng Zhang
Incyte
Gastroenterology
Medicine
Immunology
Internal medicine
Placebo
2
Papers
56
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A randomized, double-blind, placebo-controlled, dose-escalation study of the safety and efficacy of INCB039110, an oral janus kinase 1 inhibitor, in patients with stable, chronic plaque psoriasis
2016
Journal of Dermatological Treatment
Robert Bissonnette
Monica Luchi
Rosanne Fidelus-Gort
Shawnta Jackson
Haifeng Zhang
Robert Flores
Robert C. Newton
Peggy Scherle
Swamy Yeleswaram
Xuejun Chen
Alan Menter
Show All
Source
Cite
Save
Citations (43)
Long-term Results From a Phase II Open-label Study of Ruxolitinib in Patients With Essential Thrombocythemia Refractory to or Intolerant of Hydroxyurea
2014
Blood
Srdan Verstovsek
Francesco Passamonti
Alessandro Rambaldi
Giovanni Barosi
Elisa Rumi
Elisabetta Gattoni
Lisa Pieri
Haifeng Zhang
Mario Cazzola
Hagop M. Kantarjian
Tiziano Barbui
Alessandro M. Vannucchi
Show All
Source
Cite
Save
Citations (13)
1